It’s not that we want to go the FDA route per se – the tech that we’re developing would simply require it. The expertise that we have at PanLabs is mostly in synthetic biology, which lends itself to developing new biologic drugs, which are regulated by the FDA. However, we’re not ruling out the possibility of going the drug-free route with future research programs; it would just be a matter of capacity-building first.
Hi Luke, thanks for your question!
It’s not that we want to go the FDA route per se – the tech that we’re developing would simply require it. The expertise that we have at PanLabs is mostly in synthetic biology, which lends itself to developing new biologic drugs, which are regulated by the FDA. However, we’re not ruling out the possibility of going the drug-free route with future research programs; it would just be a matter of capacity-building first.